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Edited by Vladimir SkulachevAbstract We report here that alpha-lipoic acid (a-LA), a natu-
rally-occurring antioxidant, scavenges reactive oxygen species
(ROS) followed by an increase in apoptosis of human hepatoma
cells. Apoptosis induced by a-LA was dependent upon the activa-
tion of the caspase cascade and the mitochondrial death path-
way. a-LA induced increases in caspase-9 and caspase-3 but
had no signiﬁcant eﬀect on caspase-8 activity. Apoptosis induced
by a-LA was found to be mediated through the tensin homologue
deleted on chromosome 10 (PTEN)/Akt pathway. Prior to cell
apoptosis, PTEN was activated and its downstream target Akt
was inhibited. Our ﬁndings indicate that increasing ROS scav-
enging could be a therapeutic strategy to treat cancer.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Alpha-lipoic acid (a-LA) is a naturally-occurring co-factor
found in a number of multi-enzyme complexes regulating
metabolism [1]. a-LA or its reduced form dihydrolipoic acid
(DHLA) is a powerful antioxidant, it can scavenge various
ROS including superoxide radicals, hydroxyl radicals, hypo-
chlorous acid, peroxyl radicals, and singlet oxygen [1,2]. a-li-
poic acid has been reported to induce apoptosis in various
tumor cell lines such as colon cancer [3], human squamous cell
carcinoma cell line [4] and human lung epithelial cancer cells
[5]. However, the molecular mechanisms underlying the apop-
totic eﬀect of a-LA are not well understood.Abbreviations: a-LA, a-lipoic acid; DCFH-DA, dichloroﬂuorescein
diacetate; DHLA, dihydrolipoic acid; PI3K, phosphoinositide 3-
kinase; PtdIns(3,4,5)P3, phosphatidyl inositol-3,4,5-triphosphate;
PtdIns(4,5)P3, phosphatidyl inositol-4,5-triphosphate; PKB/Akt, pro-
tein kinase B/Akt; PTEN, tensin homologue deleted on chromosome
10; ROS, reactive oxygen species; TUNEL, terminal deoxynucleotidyl
transferase mediated dUTP Nick End Labelling
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doi:10.1016/j.febslet.2008.04.021Reactive oxygen species (ROS) are emerging as critical sig-
naling molecules [6]. Under normal conditions, ROS are main-
tained within narrow boundaries by scavenging systems.
Unlike normal cells, tumor cells survive in a speciﬁc redox
environment where ROS levels are elevated. Increased ROS
levels contribute to enhanced cell proliferation and suppres-
sion of apoptosis in cancer cells [7]. Previous studies have
shown that low dose exogenous ROS can promote tumor cells
proliferation [8]. Increasing ROS scavenging, thereby dampen-
ing ROS signaling could inhibit tumor growth and induce tu-
mor cell apoptosis.
Phosphatidylinositol 3-kinase (PI3K) and its eﬀector protein
kinase B (PKB/Akt) have been implicated as critical mediators
of survival [9,10]. We have previously described that ROS are
involved in cell proliferation through regulating Akt (PKB)
[11,12]. Therefore, the antioxidant a-LA could also target the
Akt pathway.
The purpose of this study was to investigate the molecular
mechanisms regulating a-LA-mediated apoptosis using
SMMC-7721 hepatoma cells. We examined the eﬀect of a-
LA on hepatoma cell apoptosis and the pathways involved.2. Materials and methods
2.1. Materials
2 0,7 0-Dichloroﬂuorescein diacetate (DCFH-DA) was purchased from
Calbiochem. Caspase-3 ﬂuorogenic substrate (Ac-DEVD-AMC), cas-
pase-8 ﬂuorogenic substrate (IETD-AMC) and caspase-9 ﬂuorogenic
substrate (LEHD-AMC) were from Alexis Biochemicals. Anti-Akt,
anti-phospho-Akt (Ser-473), anti-tensin homologue deleted on chro-
mosome 10 (PTEN), and anti-phospho-PTEN antibodies (Ser-380/
Thr-382/-383) were purchased from Cell Signaling. Anti-b-actin and
anti-horseradish peroxidise (HRP)-conjugated antibodies were from
Santa Cruz Biotechnology. BCA protein assay reagent was from
PIERCE. Culture media and fetal bovine serum were fromGibco/BRL.
2.2. Cell culture
The 7721 human hepatoma cell line was obtained from Shanghai
Institute of Cell Biology, Chinese Academy of Sciences. Cells were cul-
tured in RPMI 1640 medium supplement with 10% fetal calf serum,
200 lg/ml penicillin, 300 lg/ml glutamine. a-LA dissolved in 1 N
NaOH and neutralized in medium, was added to the culture media
to the ﬁnal concentrations speciﬁed in the text. Control cells were trea-
ted with an equivalent amount of the solvent alone.
2.3. Measurement of intracellular ROS
The intracellular ROS production was measured as described before
[11]. Brieﬂy, the cells were incubated 30 min at 37 C with 10 lM 2 0,7 0-
DCFH-DA in PBS. After washing out the excess probe, the cells wereblished by Elsevier B.V. All rights reserved.
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1668 D. Shi et al. / FEBS Letters 582 (2008) 1667–1671transferred to a ﬂuorometer cuvette, and the ﬂuorescence was recorded
at 490 nm excitation and 530 nm emission in a Hitachi F-3000 ﬂuores-
cence spectrophotometer. Intracellular ROS production was calculated
from an H2O2 standard curve.0
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*2.4. Assessment of cell viability
Cells were trypsinized with 0.25% trypsin and harvested at diﬀerent
time point. Cell number was counted using a haemocytometer by add-
ing 0.2% trypan blue which stains the cytoplasm of dead cells but not
live cells. Live cells were counted using this trypan blue exclusion
method.0h 6h 12h 18h
Fig. 1. a-LA scavenges ROS in SMMC-7721 human hepatoma cells.
Plots show ﬂuorescence intensity over 104 cells at the indicated time
after treatment. Cells were treated with 5 mM a-LA for 6, 12, and 18 h.
After treatment the cells were loaded with DCFH-DA and ﬂuorescence
was recorded at 490 nm excitation and 530 nm emission as described in
Section 2. Values are means ± S.D. *, P < 0.05 versus control.2.5. Apoptosis assay and ﬂow cytometry
SMMC-7721 cell apoptosis was assessed by terminal deoxynucleoti-
dyl transferase (Tdt) mediated dUTP Nick End Labelling (TUNEL)
analysis using ﬂow cytometry. 106 cells were washed twice in PBS
and ﬁxed in 1% paraformaldehyde in PBS at 4 C for 30 min followed
by post-ﬁxation in 70% ethanol for 30 min. Cells were subsequently
stained using the ApoBrdu kit (Phoenix Flow systems) according to
the manufactures protocol. 450 ll of RNase/propidium iodide solution
was subsequently added and incubated for 30 min at room tempera-
ture. Samples were analyzed on a Becton Dickinson FACS Calibur
(San Jose, USA).2.6. Caspase activity assay
Caspase activity was determined by ﬂuorometric assay using the en-
zyme substrate Ac-DEVD-amino-4-methyl coumarin (AMC) for cas-
pase-3, IETD-AMC for caspase-8 and LEHD-AMC for caspase-9,
which are speciﬁcally cleaved by the respective enzymes at the Asp res-
idue to release the ﬂuorescent group, AMC. Cells were processed
according to the manufactures protocol. 5 · 105 cells were centrifuged.
Cell pellets were re-suspended in PBS and subsequently 12.3 ll of
substrate was added. Following incubation at 37 C for 60 min, the
liberated ﬂuorescent product was determined ﬂuorometrically at
the excitation and emission wavelengths of 488 and 576 nm, respec-
tively.2.7. Western blot analysis of Akt and PTEN
Cell extracts were prepared by incubating the cells in lysis buﬀer
(50 mM Tris pH 7.5, 150 mM NaCl, 0.1% triton X-100, 1 mM PMSF,
2.5 lg/ml leupeptin, 1% aprotinin, 10 mM sodium Vanadate, 10 mM b
glycerol phosphate) for 30 min on ice. Equal amount of proteins per
sample (30 lg) were resolved on a 10% SDS–polyacrylamide gel elec-
trophoresis and transferred onto nitrocellulose membrane. The trans-
ferred membranes were blocked for 1 h in 5% non-fat dry milk in
0.1% Tween 20 in Tris-buﬀered saline (TBS) and incubated with
appropriate primary antibodies at 4 C overnight. Membranes were
washed three times with 0.1% Tween 20 in TBS for 10 min and incu-
bated with secondary antibodies for 1 h at room temperature. Anti-
body binding protein bands were detected by using enhanced
chemoluminescence reagent (ECL) and X-ray ﬁlm.0
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Fig. 2. Eﬀect of a-LA on the proliferation of SMMC-7721 human
hepatoma cells. SMMC-7721 hepatoma cells were treated with 1, 2.5,
and 5 mM a-LA. Cells were harvested at 1–4 days after treatment.
Viable cells were assessed by live cell counting using trypan blue
exclusion method. The values represent the means ± S.D. from three
separate experiments.3. Results
3.1. a-LA scavenges ROS in SMMC 7721 human hepatoma cells
We examined the eﬀect of a-LA on ROS generation in hep-
atoma cells. Cellular ROS was examined using the ﬂuorescent
probe DCF-DA, which detects hydroperoxide and O2 . The
validation of the ROS detection by DCF ﬂuorescence was ver-
iﬁed by ESR method as described in our previous work [12].
The changes in DCF ﬂuorescence intensity of probes reﬂected
the variation in intracellular ROS in our experiment (data were
not shown). Fig. 1 shows that treatment of SMMC-7721 cells
with 5 mM a-LA caused a rapid suppression of ROS level by
6 h which remained decreased for 18 h, as indicated by the de-
crease in DCF ﬂuorescence intensity. This suggests that a-LA
was able to scavenge intracellular ROS.3.2. a-LA inhibits cell growth in SMMC-7721 human hepatoma
cells
SMMC-7721 hepatoma cells were cultured in the presence or
absence of various concentration of a-LA for 4 days. Cell
growth was assessed at 24 h intervals by live cell counts using
the trypan blue exclusion method. Treatment with increasing
concentrations of a-LA (1, 2.5 and 5 mM) resulted in a dose-
and time-dependent decrease of viable cell number compared
to control (Fig. 2). In particular, a signiﬁcant inhibition of cell
growth 2 days after treatment with the 2.5 and 5 mM concen-
trations of a-LA was observed.
3.3. a-LA induces apoptosis in SMMC-7721 human hepatoma
cells
In order to understand whether the inhibition of cell growth
is the consequence of apoptosis, we analyzed the apoptosis in
the cells treated with 5 mM a-LA at diﬀerent times by TUNEL
as described in Section 2. As shown in Fig. 3, treatment of
SMMC-7721 cells with 5 mM a-LA caused a time-dependent
increase of apoptotic cells from day 3 onwards. By day 3
18% of the cells were apoptotic compared to 1.3% in the con-
trol study. By day 4 the percentage of apoptotic cells had
reached 65%.
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Fig. 3. a-LA induces apoptosis in SMMC-7721 human hepatoma cells. SMMC-7721 hepatoma cells were cultured for 1– 4 days with 5 mmol/L a-
LA. Cells were harvested at 1–4 days after treatment. Apoptosis was evaluated by TUNEL as described in Section 2. Results are the means ± S.D.
from three separate experiments. *P < 0.05 compared to control.
D. Shi et al. / FEBS Letters 582 (2008) 1667–1671 16693.4. Eﬀect of a-LA on caspase activation in SMMC 7721
hepatoma cells
Apoptosis is a process modulated by the caspase family of
enzymes [13,14]. We therefore examined whether apoptosis in-
duced by a-LA was dependent upon the activation of the cas-
pase cascade. The activities of caspases (3, 8 and 9) were
detected following 3 days of treatment by high dose of 5 mM
a-LA. Caspase activity assays showed that a-LA induced a
4.2-fold increase in caspase-3 and 6.3-fold increase in cas-
pase-9, but had no signiﬁcant eﬀect on caspase-8 activity
(Fig. 4). It is known that caspase-9 mediates the intrinsic0
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Fig. 4. Eﬀect of a-LA on caspase activation in SMMC-7721 human
hepatoma cells. SMMC-7721 hepatoma cells were harvested following
3 days of treatment by 5 mM a-LA. The activities of caspases (3, 8, and
9) were measured using ﬂuorogenic substrate assay as described in
Section 2. Results are the means ± S.D. from three separate exper-
iments. *P < 0.05 compared to control.(mitochondrial) pathway of apoptosis and caspase-8 mediates
the extrinsic (death receptor) pathway [15,16]. Therefore the
results suggest that the major pathway of apoptosis induction
by a-LA is the mitochondrial death pathway.
3.5. a-LA causes Akt inhibition associated with PTEN activation
Akt (PKB), a serine–threonine protein kinase, is very impor-
tant in regulating cell survival and prevention of apoptosis in
tumors [17]. We examined whether a-LA-induced caspase acti-
vation could be associated with downregulation of Akt. As
shown in Fig. 5A, treatment of SMMC 7721 hepatoma cells
with a-LA caused an initial downregulation in the levels of
the phosphorylated form of Akt at 12 h and a signiﬁcant de-
crease after 48 h of treatment. The total Akt had no signiﬁcant
change up to 72 h. a-LA-induced apoptosis appears to be
accompanied inhibition of Akt activity. It is known that Akt
phosphorylation of caspase-9 leads to inhibition of its protease
activity [18]. The data suggests that downregulation of Akt
activity by a-LA may account for a-LA-induced caspase acti-
vation and apoptosis.
Akt is the main downstream target of PI3K. We then tested
whether the decrease of Akt activity might be caused by a de-
creased PI3K activity. However, PI3K activity had no signiﬁ-
cant change in response to a-LA (data were not shown). Thus,
Akt inactivation was unlikely because of a decrease in PI3K.
Then we examined if the phosphatase PTEN, which is a nega-
tive regulator of Akt, might cause the downregulation of Akt
activity. As shown in Fig. 5B, a-LA caused a time-dependent
activation of PTEN activity. PTEN phosphorylation at Ser-
380 and Thr-382/-383 was initially elevated at 12 h and con-
tinue to increase until 72 h. The PTEN phosphorylation state
Phospho-PTEN
β-actin
PTEN
hours 0 12 24 48 72
A 
B 
Phospho-Akt 
Akt 
β-actin
hours 0 12 24 48 72
Fig. 5. a-LA causes inactivation of Akt and activation of PTEN. Cells
were treated with 5 mM a-LA for the indicated period. (A) Eﬀect of a-
LA on Akt expression and phosphorylation. Protein extracts were
blotted using anti-phospho-Akt (Ser 473), anti-Akt and anti-b-actin
antibodies as described in Section 2. (B) Eﬀect of a-LA on PTEN
expression and phosphorylation. Protein extracts were blotted using
anti-phospho-PTEN (Ser-380/Thr-382/-383), anti-PTEN, and anti-b-
actin antibodies as described in Section 2. The present blots are
representative of three experiments.
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tion. This suggests that a-LA, through activating PTEN, neg-
atively regulated Akt.4. Discussion
Growing evidence shows that ROS plays a critical role in
various cancers[19,20]. Cancer cells usually have elevated levels
of ROS and downregulation of ROS scavengers and antioxi-
dant enzymes. Antioxidant treatment could increase antioxida-
tive activity and induce cancer cell apoptosis [21]. a-Lipoic acid
is one of the important naturally occurring antioxidants that
are synthesized by plants and animals [1]. It has been reported
that a-LA has a beneﬁcial eﬀect in patients with advanced can-
cer through increasing glutathione peroxidase activity and
reducing oxidative stress [22]. Recent studies have also shown
that a-LA induces apoptosis in some cancer and transformed
cell lines [3,4,23]. However, the mechanisms by which a-LA in-
duces cancer cell apoptosis is unclear.
To test whether a-LA can also induce apoptosis in human
hepatoma cells and to determine the mechanisms leading to
this, we ﬁrst characterized the cellular ROS level and apoptosis
response to a-LA treatment in SMMC-7721 cells. Our results
demonstrate that a-LA is able to scavenge ROS in SMMC-
7721 human hepatoma cells. The reduction of ROS by a-LA
was followed by hepatoma cells growth arrest and apoptosis.
Five millimoles a-LA caused a signiﬁcant reduction of ROS
for at least 18 h, followed by signiﬁcant growth inhibition from
day 2, and apoptosis from day 3.
Apoptosis can be initiated through an extrinsic pathway,
also referred to as the death receptor pathway; and an intrinsic
pathway, also referred to as the mitochondrial pathway. We
further investigated by which apoptotic pathway a-LA in-
duced apoptosis in hepatoma cells. The principal executioners
of apoptotic cell death are caspase proteases which belong to a
family of cysteine proteases. The extrinsic pathway is associ-ated with activation of caspase-8, and the mitochondrial path-
way with activation of caspase-9. The two pathways converge
into caspase-3 activation and trigger apoptosis [15,16,24]. Our
results show that apoptosis induced by a-LA was dependent
upon the activation of the caspase cascade. a-LA induced in-
crease in caspase-3 and caspase-9 but had no signiﬁcant eﬀect
on caspase-8 activity. The ability of a-LA to activate caspase-9
and inability of a-LA to activate caspase-8 suggests that their
apoptotic eﬀect is mediated through the mitochondrial death
pathway.
The Akt (PKB) pathway is a well-known signal transduction
pathway mediating growth promotion and cell survival signal-
ing [9,25]. Our results show that a-LA inhibited Akt activity.
Since Akt phosphorylates and inhibits the protease activity of
caspase-9 [18], inactivation of Akt by a-LA could result in acti-
vating caspase-9 and trigger apoptosis. It is known that Akt
activity can be positively regulated by PI3K or negatively reg-
ulated by PTEN. Sometimes Akt can also be directly activated
by selectively phosphorylation at Ser-473, a residue critical for
maximal activation [26]. In order to understand the mechanism
whereby a-LA induced Akt inactivation, both PI3K and PTEN
activities were investigated. The results suggest that PI3K was
unlikely to have contributed to Akt activation. PTEN activity
was inversely correlated with the degree of Akt activity, which
is consistent with the negative regulatory role of PTEN in Akt
signaling [27]. This indicates that apoptosis induced by a-LA
was mediated through the PTEN/Akt pathway.
PTEN is a phosphatidyl inositol-3,4,5-triphosphate
(PtdIns(3,4,5)P3) phosphatase which dephosphorylates of the
three position PtdIns(3,4,5)P3 to produce phosphatidyl inosi-
tol-4,5-triphosphate (PtdIns(4,5)P2), thus direct antagonizing
PI3K signaling. ROS is known to be able to inactivate protein
phosphatases by its oxidative activity. For example, PTEN
phosphatase activity was reported to be oxidatively inhibited
by ROS [28]. In this regard, scavenging cellular ROS could
activating PTEN, thus inactivating PI3K signaling and pro-
moting apoptosis. As the results we present show, the decrease
of Akt levels, the increase of PTEN and the induction of the
apoptotic process induced by a-LA may be due to the antiox-
idative eﬀect of a-LA.
At present, the role of ROS in cancer treatment has been a
controversial issue. Both stimulation and suppression of
ROS have been reported to induce cancer cell apoptosis. Some
reports suggest that a-LA does not have antioxidant eﬀects or
even may have pro-oxidant properties that induce apoptosis by
increasing ROS levels [3,5,29]. Our data show that a-LA acted
as an antioxidant. Depending on the dose, the time of expo-
sure, the type of cells and the experimental conditions, a-LA
may act diﬀerently [30]. Our results suggest that a-LA scav-
enged intracellular ROS, thus aﬀecting the cellular redox envi-
ronment in hepatoma cells. It is known that cancer cells have
an elevated level of ROS and that cellular ROS are required
for cancer cell growth. Scavenging ROS by a-LA thereby
dampened ROS signaling and depressed tumor growth. In this
respect, modulation of ROS by reducing ROS levels could con-
fer a therapeutic beneﬁt in cancer treatment. Given that cancer
cells have inherently higher levels of ROS than normal cells,
this property can be exploited to selectively kill cancer cells
but not harm normal cells. Indeed recent studies have shown
that a-LA induces apoptosis in some cancer and transformed
cell lines but not in non-transformed cell lines [3,4]. Our results
also show that 5 mM a-LA was not harmful to normal L02 li-
D. Shi et al. / FEBS Letters 582 (2008) 1667–1671 1671ver cells (data are not shown). This suggests that a-LA is a po-
tential candidate for cancer treatment.
Taken together, our ﬁndings suggest inhibition of ROS gen-
eration by a-LA eﬀectively induced apoptosis in hepatoma
cells. a-LA, through scavenging ROS, inhibits PI3K signaling
and induces mitochondrial pathway mediated apoptosis.
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